Interferon Alfa-n1

Known as: Interferon Alfa, Interferon alpha-n1 (Ins) 
A highly purified alpha interferon produced by a human lymphoid cell line. Interferon alpha-n1 consists of multiple alpha interferon subtypes, at… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-1997
012319861997

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a… (More)
Is this relevant?
Review
1997
Review
1997
Interferon alfa-n1 is produced from a lymphoid cell line and consists of multiple alpha interferon subtypes. Early studies… (More)
Is this relevant?
Review
1992
Review
1992
OBJECTIVES To review the clinical information on the use of alpha, beta and gamma interferons and to classify the use of alpha… (More)
Is this relevant?
1991
1991
BACKGROUND We earlier reported that patients with recurrent respiratory papillomatosis responded to six months of treatment with… (More)
Is this relevant?
1991
1991
One hundred sixty-five patients were randomized to receive either interferon alfa-n1 (Wellferon; Burroughs Wellcome Co, Research… (More)
Is this relevant?
1988
1988
Sixty-six patients with recurrent respiratory papillomatosis of juvenile onset were treated for six months with interferon alfa… (More)
Is this relevant?
1988
1988
Nine men with refractory condylomata acuminata were treated with intramuscular interferon alfa-n1 and the effect on their serum… (More)
Is this relevant?
1988
1988
Sixty-six patients with clinically severe juvenile-onset recurrent respiratory papillomatosis (RRP) were entered into a 12-month… (More)
Is this relevant?
Review
1986
Review
1986
Since 1959, The Wellcome Foundation Ltd. has been involved in research to develop interferon for practical use. A brief… (More)
Is this relevant?
1986
1986
Following a report on the beneficial effects of interferon administered to patients with hairy cell leukemia, a trial was… (More)
Is this relevant?